Suppr超能文献

关于胃蛋白酶抑制剂对荷瘤小鼠腹水积聚影响的进一步研究。

Further studies of the effect of pepstatin on ascites accumulation in tumor-bearing mice.

作者信息

Greenbaum L M, Esumi H, Sato S

出版信息

Cancer Lett. 1979 Jul;7(2-3):91-6. doi: 10.1016/s0304-3835(79)80101-9.

Abstract

Studies were done of the effect of pepstatin on ascites accumulation in mice bearing MM46, Ehrlich, CCM, SN36, L1210, and NTF ascites tumors. When pepstatin was injected subcutaneously at 80 mg/kg body wt before ascites accumulation, it inhibited the accumulation in all strains of the tumors tested. In MM46, CCM and NTF tumor strains there was also a decrease in the tumor cell numbers following pepstatin treatment. Kinetic studies on ascites accumulation with tumor strain MM46 demonstrated that even when pepstatin was injected after ascites accumulation it reduced the ascites volume. A dose-dependent effect was observed in this tumor strain when pepstatin was injected both before and after ascites accumulation. The results confirm previous studies of pepstatin's ability to retard ascites in L1210 and P-815Y ascites tumors and also broaden the concept of the mechanisms by which petstatin may be acting.

摘要

开展了有关胃蛋白酶抑制剂对携带MM46、艾氏、CCM、SN36、L1210和NTF腹水瘤的小鼠腹水积聚影响的研究。当在腹水积聚前以80 mg/kg体重皮下注射胃蛋白酶抑制剂时,它抑制了所有测试肿瘤菌株中的腹水积聚。在MM46、CCM和NTF肿瘤菌株中,胃蛋白酶抑制剂处理后肿瘤细胞数量也有所减少。对肿瘤菌株MM46腹水积聚的动力学研究表明,即使在腹水积聚后注射胃蛋白酶抑制剂,它也会减少腹水量。当在腹水积聚前后都注射胃蛋白酶抑制剂时,在该肿瘤菌株中观察到剂量依赖性效应。这些结果证实了先前关于胃蛋白酶抑制剂延缓L1210和P - 815Y腹水瘤腹水能力的研究,并且还拓宽了胃蛋白酶抑制剂可能起作用机制的概念。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验